2023-04-012024-03-312024-03-31false13542265NORTH ISLINGTON INTEGRATED CARE LIMITED2025-01-31falseiso4217:GBPxbrli:pure135422652023-04-01135422652024-03-31135422652023-04-012024-03-31135422652022-04-01135422652023-03-31135422652022-04-012023-03-3113542265bus:SmallEntities2023-04-012024-03-3113542265bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3113542265bus:AbridgedAccounts2023-04-012024-03-3113542265bus:PrivateLimitedCompanyLtd2023-04-012024-03-3113542265core:WithinOneYear2024-03-3113542265core:AfterOneYear2024-03-3113542265core:WithinOneYear2023-03-3113542265core:AfterOneYear2023-03-3113542265core:ShareCapital2024-03-3113542265core:SharePremium2024-03-3113542265core:RevaluationReserve2024-03-3113542265core:OtherReservesSubtotal2024-03-3113542265core:RetainedEarningsAccumulatedLosses2024-03-3113542265core:ShareCapital2023-03-3113542265core:SharePremium2023-03-3113542265core:RevaluationReserve2023-03-3113542265core:OtherReservesSubtotal2023-03-3113542265core:RetainedEarningsAccumulatedLosses2023-03-3113542265core:LandBuildings2024-03-3113542265core:PlantMachinery2024-03-3113542265core:Vehicles2024-03-3113542265core:FurnitureFittings2024-03-3113542265core:OfficeEquipment2024-03-3113542265core:NetGoodwill2024-03-3113542265core:IntangibleAssetsOtherThanGoodwill2024-03-3113542265core:ListedExchangeTraded2024-03-3113542265core:UnlistedNon-exchangeTraded2024-03-3113542265core:LandBuildings2023-03-3113542265core:PlantMachinery2023-03-3113542265core:Vehicles2023-03-3113542265core:FurnitureFittings2023-03-3113542265core:OfficeEquipment2023-03-3113542265core:NetGoodwill2023-03-3113542265core:IntangibleAssetsOtherThanGoodwill2023-03-3113542265core:ListedExchangeTraded2023-03-3113542265core:UnlistedNon-exchangeTraded2023-03-3113542265core:LandBuildings2023-04-012024-03-3113542265core:PlantMachinery2023-04-012024-03-3113542265core:Vehicles2023-04-012024-03-3113542265core:FurnitureFittings2023-04-012024-03-3113542265core:OfficeEquipment2023-04-012024-03-3113542265core:NetGoodwill2023-04-012024-03-3113542265core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3113542265core:ListedExchangeTraded2023-04-012024-03-3113542265core:UnlistedNon-exchangeTraded2023-04-012024-03-3113542265core:MoreThanFiveYears2023-04-012024-03-3113542265core:Non-currentFinancialInstruments2024-03-3113542265core:Non-currentFinancialInstruments2023-03-3113542265dpl:CostSales2023-04-012024-03-3113542265dpl:DistributionCosts2023-04-012024-03-3113542265core:LandBuildings2023-04-012024-03-3113542265core:PlantMachinery2023-04-012024-03-3113542265core:Vehicles2023-04-012024-03-3113542265core:FurnitureFittings2023-04-012024-03-3113542265core:OfficeEquipment2023-04-012024-03-3113542265dpl:AdministrativeExpenses2023-04-012024-03-3113542265core:NetGoodwill2023-04-012024-03-3113542265core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3113542265dpl:GroupUndertakings2023-04-012024-03-3113542265dpl:ParticipatingInterests2023-04-012024-03-3113542265dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3113542265core:ListedExchangeTraded2023-04-012024-03-3113542265dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3113542265core:UnlistedNon-exchangeTraded2023-04-012024-03-3113542265dpl:CostSales2022-04-012023-03-3113542265dpl:DistributionCosts2022-04-012023-03-3113542265core:LandBuildings2022-04-012023-03-3113542265core:PlantMachinery2022-04-012023-03-3113542265core:Vehicles2022-04-012023-03-3113542265core:FurnitureFittings2022-04-012023-03-3113542265core:OfficeEquipment2022-04-012023-03-3113542265dpl:AdministrativeExpenses2022-04-012023-03-3113542265core:NetGoodwill2022-04-012023-03-3113542265core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3113542265dpl:GroupUndertakings2022-04-012023-03-3113542265dpl:ParticipatingInterests2022-04-012023-03-3113542265dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3113542265core:ListedExchangeTraded2022-04-012023-03-3113542265dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3113542265core:UnlistedNon-exchangeTraded2022-04-012023-03-3113542265core:NetGoodwill2024-03-3113542265core:IntangibleAssetsOtherThanGoodwill2024-03-3113542265core:LandBuildings2024-03-3113542265core:PlantMachinery2024-03-3113542265core:Vehicles2024-03-3113542265core:FurnitureFittings2024-03-3113542265core:OfficeEquipment2024-03-3113542265core:AfterOneYear2024-03-3113542265core:WithinOneYear2024-03-3113542265core:ListedExchangeTraded2024-03-3113542265core:UnlistedNon-exchangeTraded2024-03-3113542265core:ShareCapital2024-03-3113542265core:SharePremium2024-03-3113542265core:RevaluationReserve2024-03-3113542265core:OtherReservesSubtotal2024-03-3113542265core:RetainedEarningsAccumulatedLosses2024-03-3113542265core:NetGoodwill2023-03-3113542265core:IntangibleAssetsOtherThanGoodwill2023-03-3113542265core:LandBuildings2023-03-3113542265core:PlantMachinery2023-03-3113542265core:Vehicles2023-03-3113542265core:FurnitureFittings2023-03-3113542265core:OfficeEquipment2023-03-3113542265core:AfterOneYear2023-03-3113542265core:WithinOneYear2023-03-3113542265core:ListedExchangeTraded2023-03-3113542265core:UnlistedNon-exchangeTraded2023-03-3113542265core:ShareCapital2023-03-3113542265core:SharePremium2023-03-3113542265core:RevaluationReserve2023-03-3113542265core:OtherReservesSubtotal2023-03-3113542265core:RetainedEarningsAccumulatedLosses2023-03-3113542265core:NetGoodwill2022-04-0113542265core:IntangibleAssetsOtherThanGoodwill2022-04-0113542265core:LandBuildings2022-04-0113542265core:PlantMachinery2022-04-0113542265core:Vehicles2022-04-0113542265core:FurnitureFittings2022-04-0113542265core:OfficeEquipment2022-04-0113542265core:AfterOneYear2022-04-0113542265core:WithinOneYear2022-04-0113542265core:ListedExchangeTraded2022-04-0113542265core:UnlistedNon-exchangeTraded2022-04-0113542265core:ShareCapital2022-04-0113542265core:SharePremium2022-04-0113542265core:RevaluationReserve2022-04-0113542265core:OtherReservesSubtotal2022-04-0113542265core:RetainedEarningsAccumulatedLosses2022-04-0113542265core:AfterOneYear2023-04-012024-03-3113542265core:WithinOneYear2023-04-012024-03-3113542265core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3113542265core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3113542265core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3113542265core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3113542265core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3113542265core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3113542265core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3113542265core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3113542265core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3113542265core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3113542265core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3113542265core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3113542265core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3113542265core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3113542265core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3113542265core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3113542265core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3113542265core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3113542265core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3113542265core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3113542265core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3113542265core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3113542265core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3113542265core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3113542265core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3113542265core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3113542265core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3113542265bus:Director12023-04-012024-03-3113542265bus:Director22023-04-012024-03-3113542265bus:Director32023-04-012024-03-3113542265bus:Director42023-04-012024-03-3113542265bus:Director52023-04-012024-03-3113542265bus:Director62023-04-012024-03-3113542265bus:Director72023-04-012024-03-31

NORTH ISLINGTON INTEGRATED CARE LIMITED

Registered Number
13542265
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

NORTH ISLINGTON INTEGRATED CARE LIMITED
Company Information
for the year from 1 April 2023 to 31 March 2024

Directors

Chakraborty, Anjan, Dr
Hira, Jyotsna, Dr
Ivens, Kate
Kalimuthu, Subhashini, Dr
Kateb, Heskel Jospeh, Dr
Koya, Milan Mahendra, Dr
Rachi, Mohamed

Registered Address

Stroud Green Medical Clinic
181 Stroud Green Road
London
N4 3PZ

Registered Number

13542265 (England and Wales)
NORTH ISLINGTON INTEGRATED CARE LIMITED
Balance Sheet as at
31 March 2024

Notes

2024

2023

£

£

£

£

Current assets
Debtors3747,347578,624
747,347578,624
Creditors amounts falling due within one year4(387,945)(251,400)
Net current assets (liabilities)359,402327,224
Total assets less current liabilities359,402327,224
Provisions for liabilities(356,330)(324,153)
Net assets3,0723,071
Capital and reserves
Called up share capital77
Profit and loss account3,0653,064
Shareholders' funds3,0723,071
The financial statements were approved and authorised for issue by the Board of Directors on 31 January 2025, and are signed on its behalf by:
Chakraborty, Anjan, Dr
Director
Registered Company No. 13542265
NORTH ISLINGTON INTEGRATED CARE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20242023
Average number of employees during the year367
3.Debtors: amounts due within one year

2024

2023

££
Other debtors723,752360,096
Prepayments and accrued income23,595218,528
Total747,347578,624
4.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables149,556149,414
Taxation and social security-719
Other creditors18,975960
Accrued liabilities and deferred income219,414100,307
Total387,945251,400